Skip to content
10-Q

Quarterly Report

SPARK THERAPEUTICS, INC.

0001609351-19-000072

← back to feed
Filed
Nov 7, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 1, 2019 38.52M sh
Capex Q3 2019 · Sep 30, 2019 $17.68M
Capex Q3 2019 · Sep 30, 2018 $14.92M
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$100.45M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$28.04M
Long Term Debt Q3 2019 · Sep 30, 2019 $41.34M
Long Term Debt Q3 2019 · Dec 31, 2018 $46.09M
Short Term Debt Q3 2019 · Sep 30, 2019 $7.83M
Short Term Debt Q3 2019 · Dec 31, 2018 $4.82M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $207.14M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $95.25M
Stockholders Equity Q3 2019 · Sep 30, 2019 $346.01M
Stockholders Equity Q3 2019 · Jun 30, 2019 $401.6M
Stockholders Equity Q3 2019 · Dec 31, 2018 $496.51M
Stockholders Equity restated Q3 2019 · Sep 30, 2018 $549.87M
Stockholders Equity Q3 2019 · Jun 30, 2018 $583.74M
Stockholders Equity Q3 2019 · Dec 31, 2017 $513.62M
Current Liabilities Q3 2019 · Sep 30, 2019 $100.3M
Current Liabilities Q3 2019 · Dec 31, 2018 $62.35M
Total Liabilities Q3 2019 · Sep 30, 2019 $357.49M
Total Liabilities Q3 2019 · Dec 31, 2018 $317.84M
Current Assets Q3 2019 · Sep 30, 2019 $467.95M
Current Assets Q3 2019 · Dec 31, 2018 $567.14M
Total Assets Q3 2019 · Sep 30, 2019 $703.5M
Total Assets Q3 2019 · Dec 31, 2018 $814.35M
Net Income Q3 2019 · Sep 30, 2019 −$66.6M
Net Income Q3 2019 · Sep 30, 2019 −$185.19M
Net Income Q3 2019 · Sep 30, 2018 −$47.36M
Net Income Q3 2019 · Sep 30, 2018 −$13.57M
Operating Income Q3 2019 · Sep 30, 2019 −$68.66M
Operating Income Q3 2019 · Sep 30, 2019 −$191.95M
Operating Income Q3 2019 · Sep 30, 2018 −$51.75M
Operating Income Q3 2019 · Sep 30, 2018 −$135.26M
Revenue Q3 2019 · Sep 30, 2019 $22.45M
Revenue Q3 2019 · Sep 30, 2019 $56.72M
Revenue restated Q3 2019 · Sep 30, 2018 $10.71M
Revenue restated Q3 2019 · Sep 30, 2018 $51.57M